Page last updated: 2024-08-21

hydrazine and Parkinson Disease

hydrazine has been researched along with Parkinson Disease in 223 studies

Research

Studies (223)

Timeframe	Studies, this research(%)	All Research%
pre-1990	217 (97.31)	18.7374
1990's	4 (1.79)	18.2507
2000's	1 (0.45)	29.6817
2010's	1 (0.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, N; Guo, Z; Han, M; Huang, Y; Liu, J; Xu, S	1
Iadgarov, IS; Kandel', EI	1
Bitton, V; Globus, M; Hefti, F; Melamed, E	1
Goldstein, M; Gopinathan, G; Hiesiger, E; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R	1
Gerdes, U; Lehmann, K; Ulm, G	1
Liu, DK	3
Anderson, GM; Chouinard, G; Gauthier, S; Purdy, WC; Young, SN	1
Dean, BC; McLellan, DL	1
Caraceni, T; Cocchi, D; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A	1
Agnoli, A; Baldassarre, M; D'Urso, R; De Giorgio, G; Falaschi, P; Rocco, A; Ruggieri, S	1
Caraceni, T; Giovannini, P; Martinez-Campos, A; Müller, EE; Novelli, A; Parati, E	1
Gulliver, PA; Hagan, RM; Raxworthy, MJ	1
Beiske, A; Fotteler, B; Jorga, KM; Larsen, JP; Moe, B; Schleimer, M; Schmitt, M	1
Canals, S; Casarejos, MJ; de Bernardo, S; Mena, MA; Rodríguez-Martín, E	1
Walker, E	1
Leibowitz, M; Lieberman, A	1
Birket-Smith, E; Dupont, E; Hansen, E; Hyyppä, M; Marttila, R; Mikkelsen, B; Pakkenberg, H; Presthus, J; Rinne, UK	1
Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P	1
Lipper, S	1
Ambrozi, L; Birkmayer, W; Riederer, P; Youdim, MB	1
Coxon, A; Greenacre, JK; Petrie, A; Reid, JL	1
Gilland, O	1
Ogawa, M; Tohgi, H	1
Savery, F	2
Battistin, L; Meneghetti, G; Rigotti, S; Saia, A	1
Diamond, SG; Markham, CH; Treciokas, LJ	1
Cotzias, GC; Miller, ST; Papavasiliou, PS; Rosal, VL	1
Dorner, A; Wajsbort, E; Wajsbort, J	1
Hokkanen, E; Myllylä, VV; Saarinen, A; Tokola, O	1
Carlyle, D; Williams, BO	1
Martin, S	1
Hirayama, K; Kondo, T; Kuruma, I; Narabayashi, H; Yokochi, M	2
Green, J; Haycook, W; Kilgore, M; Stephens, R	1
Birkmayer, W; Mentasti, M; Podiwinsky, F; Riederer, P	1
Barone, DA; Martin, HL	1
Bernstein, RM	1
Bender, DA; Earl, CJ; Lees, AJ	1
Conte, P; Julien, J; Moulinier, J; Reiffers, J	1
Estey, E; Goldstein, M; Gopinathan, G; Lieberman, A; Ohashi, T; Sauter, A	1
Jotkowitz, S	1
Hershman, JM; Wingert, TD	1
Mölsä, P; Rinne, UK	1
Caraceni, TA; Celano, I; Girotti, F; Parati, E	1
Coscia, CJ; Mitchell, J	1
Klawans, HL; Kramer, J; Nausieda, PA; Wiener, WJ	1
Deze, J; Völler, GW	1
Gerlach, J	1
Avery, GS; Brogden, RN; Pinder, RM; Sawyer, PR; Speight, TM	1
Hanzal, F	2
Chouza, C; Gomensoro, JB; Romero, S	3
Lee, MC; Lippert, DM; Loewenson, RB; Martin, WE; Resch, JA; Tolosa, ES	1
Bianchine, JR	1
Anderson, F; Joynt, R; Rivera-Calimlim, L; Tandon, D	1
Hayek, J	1
Herishanu, Y; Rosenberg, P	1
Algeri, S; Campanella, G; Cerletti, C; Dolfini, E; Jori, A; Rinaldi, F	1
Agid, Y; Lhermitte, F; Signoret, JL; Studler, JM	1
Rampton, DS	1
De la Garza, R; Lombardo, L	1
Barbeau, A; Roy, M	1
Lin, JT; Ziegler, DK	1
True, AC	1
Siegfried, J; Zumstein, H	2
Goodwin, BL; Johnson, RD; Ruthven, CR; Sandler, M	1
Bass-Verrey, F; Ludin, HP	1
Carrera, N; Marti-Masso, JF; Martínez-Lage, JM	1
Mizuno, Y; Obayashi, T; Ueki, A; Yoshida, M	1
Londoõ, R	1
Omoto, T	1
Gabreëls, FJ; Joosten, EM; Keyser, A; Korten, JJ	1
Jaatoul, N; Kertesz, A; McInnis, W; Paty, DW	1
Goodgold, A; Jonas, S; Leibowitz, M; Lieberman, A	1
Baker, AB; Lee, MC; Loewenson, RB; Martin, WE; Resch, JA; Tolosa, ES	1
Critchley, E	1
Birkmayer, W; Danielczyk, W; Neumayer, E; Riederer, P	2
Birket-Smith, E	1
McDowell, FH; Stern, PH; Sweet, RD; Wasterlain, CG	1
Kishikawa, H; Ohmoto, T	1
Rinne, UK; Siirtola, T; Sonninen, V	3
Cerone, G; Nurzia, A; Pirro, R; Vacca, U	1
Celesia, GG; Wanamaker, WM	1
Nevsímal, O; Roth, B; Vymazal, J	1
Birket-Smith, E; Dupont, E; Hansen, E; Mikkelsen, B; Pakkenberg, H; Presthus, J; Rautakorpi, I; Riman, E; Rinne, UK	1
Hildick-Smith, M	1
Ceballos-Baumann, AO; Eckert, W; von Kummer, R; Weicker, H	1
Blackburn, NA; Boddie, HG; Ellis, CJ; Kendal, BR; MacMahon, DG; Sachdev, D	1
Berger, HJ; Horstink, MW; Pasman, JW; van't Hof, MA; Zijlmans, JC	1
Kraus, P; Kuhn, W; Przuntek, H	1
Rinne, JO; Rinne, UK	1
Dordain, G; Dostert, P; Strolin Benedetti, M; Vernay, D	1
Dichgans, J; Scholz, E	1
Albani, C; Hacisalihzade, SS; Mansour, M	1
Cossutta, E; Ferrante, C; Pezzoli, G; Scarlato, G; Tesei, S; Zecchinelli, A	2
Aljanati, R; Caamaño, JL; Chouza, C; de Medina, O; Romero, S; Scaramelli, A	1
Dupont, E; Hansen, E; Jensen, NO; Mikkelsen, B; Mikkelsen, BO	2
Stern, G	1
Mondal, BK; Mondal, KN	1
Birkmayer, GD; Birkmayer, W	1
Csanda, E; Takáts, A; Tárczy, M	1
Dostert, P; Strolin Benedetti, M	1
Kuhn, W; Przuntek, H	1
Aymard, N; Holzer, J; Rondot, P; Ziegler, M	2
Marion, MH; Marsden, CD; Quinn, NP	1
Jenner, P; Malcolm, SL; Marion, MH; Marsden, CD; Quinn, NP; Stocchi, F	1
Ludin, HP	1
D'Andrea, G; Durisotti, C; Ferro-Milone, F; Lion, P; Lorizio, A; Nordera, GP	1
Baas, H; Fischer, PA	1
Lees, AJ; Poewe, WH; Stern, GM	1
Heersema, T; Jansen, EN; Meerwaldt, JD; Speelman, JD; van Manen, J	1
Jansen, EN; Meerwaldt, JD	1
Rinne, UK	2
Lees, AJ	1
Aljanati, R; Caamano, JL; Chouza, C; de Medina, O; Gonzales Panizza, V; Romero, S; Scarmelli, A	1
Siegfried, J	1
Perry, TL; Yong, VW	1
Jenner, P; Marion, MH; Marsden, CD; Quinn, NP; Stocchi, F	1
Berglund, B; Kaijser, L; Sachs, C	1
Azevedo, M; Coelho, H; Manso, C	1
Yu, HZ	1
Barbeau, A; Giroux, JM	1
Barbeau, A; Dubuc, R; Giroux, JM	1
Birkmayer, W; Neumayer, E	1
Agnoli, A; Barba, C; Casacchia, M; Fazio, C; Reitano, M; Ruggieri, S; Volante, F	1
Chase, TN; Fermaglich, J	1
Marsden, CD; Parkes, JD; Rees, JE	1
Christiani, K; Möller, WD	1
Birkmayer, W	1
Birkmayer, W; Linauer, W; Mentasti, M; Riederer, P	1
Glasgow, GL; Henley, JW; Willoughby, EW	1
Birkmayer, W; Mentasti, M	1
Gershon, S; Wallach, MB	1
Delesie, R; Fahn, S; Prasad, AL	1
Sourkes, TL	1
Bartholini, G; Fletscher, A; Kuruma, I; Tissot, R	1
Rondot, P	1
de la Garza, R; Ivan-Reynoso, G; Lombardo, L	1
Braham, J; Sarova-Pinhas, I	1
Cotzias, GC; Mena, I; Papavasiliou, PS	1
Campanella, G; Pennetta, R	1
Masi, G; Megna, GF; Puca, FM; Specchio, LM	1
Dietrichson, P	2
Dupont, E; Hansen, E; Holm, P; Melsens, S; Parkenberg, H	1
Holmsen, R; Kvan, L; Presthus, J; Thoresen, GB	1
Pekkarinen, A; Rinne, UK; Salokangas, R; Siirtola, T; Sonninen, V	1
Fermaglich, J	1
Bell, MA; Cotzias, GC; Düby, SE; Fehling, C; Papavasiliou, PS; Steck, AJ	1
Wanger, SL	1
Gattringer, B; Steinhäusl, H	1
Allen, JG; Calne, DB; Davies, CA; Reid, JL; Vakil, SD	1
Chase, TN; Ng, LK; Watanabe, AM	1
Stammler, A; Vielhaber, K	1
Steinhäusl, H	1
Mones, RJ	2
Olanow, CW; Schwartz, AM; Spencer, A	1
Andrews, CJ; Somerville, B	1
Eisenlohr, JJ; Gehlen, W	1
Schönfelder, H; Wälzholz, U	1
Calne, DB; George, CF; Reid, JL; Vakil, SD	1
Glass, J	1
Kesten, M; Streifler, M; Vardi, J	1
Rinne, UK; Sonninen, V	1
Mars, H	3
de Ajuriaguerra, J; Tissot, R	1
Barry, PE; Marsden, CD; Parkes, JD; Zilkha, KJ	1
Fischer, PA; Jacobi, P; Maxion, H; Schneider, E	1
Klawans, HL; Ringel, SP	1
Birkmayer, W; Danielcyk, W; Neumayer, E; Riederer, P	1
Bartholini, G; Constantinidis, J; de Ajuriaguerra, J; Eisenring, JJ; Geissbühler, F; Tissot, R; Yanniotis, G	1
Court, J; Kase, JC; Mena, I; Palacios, E	1
Cavagnini, F; Malinverni, A; Peracchi, M; Pontiroli, AE; Raggi, U	1
Van Wieringen, A	1
Pakkenberg, H	1
Diamond, SG; Markham, C; Treciokas, LJ	1
Jordan, JC; Schwartz, DE; Ziegler, WH	1
Brody, JA; Chase, TN; Holden, EM	1
Fahn, S	1
Miller, EM; Wiener, L	1
Fujimori, N; Itoga, E; Kito, S; Kosaka, K; Yamamoto, M	1
Calne, DB; Gawler, J; Hilson, A; Pallis, CA; Petrie, A; Rao, S; Reid, JL; Thomas, PK; Vakil, SD	1
Gorkin, VZ	1
Calne, DB; Petrie, A; Rao, S; Reid, JL; Vakil, SD	1
Barbeau, A; Botez, MI; Joubert, M; Mars, H	1
Arsenault, A; Barbeau, A; Gillo-Joffroy, L; Mars, H	1
Chase, TN; Watanabe, AM	1
Barrera, ER; Bennett, S; Mars, H	1
Ebadi, M; Pfeiffer, R	1
Constantinidis, J; Eisenring, JJ; Geissbühler, F; Krassoievitch, M; Tissot, R; Yanniotis, G	1
Alfandary, I; Hemli, JA; Siegfried, J; Wajsbort, J; Yahel, M	1
Krall, J; Mars, H	1
Klawans, HL; Ringel, SP; Shenker, DM	1
Barrett, RE; Duvoisin, RC; Mendoza, MR; Schear, MJ; Yahr, MD	1
Cotzias, GC; Dahl, LK; Düby, SE	1
Cotzias, GC	1
Chase, TN	1
De Ajuriaguerra, J; Gaillard, JM; Gauthier, G; Guggisberg, M; Tissot, R	1
Anzil, AP	1
Barrett, RE; St Balch, T	1
Tissot, R	1

Reviews

7 review(s) available for hydrazine and Parkinson Disease

Article	Year
Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. Drugs, 1976, Volume: 11, Issue:5 Topics: Benserazide; Binding Sites; Carbidopa; Carboxy-Lyases; Drug Interactions; Humans; Hydrazines; Kinetics; Levodopa; Liver Function Tests; Parkinson Disease	1976
Overview of the present state of MAO inhibitors. Journal of neural transmission. Supplementum, 1987, Volume: 23 Topics: Animals; Benzamides; Humans; Hydrazines; Isoquinolines; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Parkinson Disease; Phenethylamines; Piperidines; Selegiline; Structure-Activity Relationship	1987
[Modern treatment of parkinsonism]. Zeitschrift fur Neurologie, 1972, Volume: 202, Issue:4 Topics: Antiparkinson Agents; Brain Stem; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Hydrazines; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Parkinson Disease; Psychoses, Substance-Induced; Serotonin; Tryptophan	1972
The management of Parkinson's syndrome. The Medical clinics of North America, 1972, Volume: 56, Issue:3 Topics: Adult; Aged; Amantadine; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Stereotaxic Techniques; Thalamus; Thinking	1972
Recent advances in the treatment of Parkinsonism with drugs. Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain Barrier; Brain; Central Nervous System; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Drug Tolerance; Humans; Hydrazines; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Vomiting	1972
[Decarboxylase inhibitor given in combination with l-dopa. A new therapeutic principal in parkinsonism]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Oct-10, Volume: 93, Issue:28 Topics: Administration, Oral; Animals; Benserazide; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Hydrazines; Parkinson Disease; Time Factors	1973
[New data on monoamine oxidase inhibitors]. Vestnik Akademii meditsinskikh nauk SSSR, 1971, Volume: 26, Issue:11 Topics: Acridines; Animals; Brain; Cytoplasm; Hydrazines; Iproniazid; Isoquinolines; Liver; Membranes; Mitochondria; Monoamine Oxidase Inhibitors; Oxadiazoles; Pargyline; Parkinson Disease; Pyridines; Pyrroles; Radiation Injuries; Rats; Tranylcypromine; Vitamin D	1971

Trials

64 trial(s) available for hydrazine and Parkinson Disease

Article	Year
The effect of tolcapone on the pharmacokinetics of benserazide. European journal of neurology, 1999, Volume: 6, Issue:2 Topics: Aged; Antiparkinson Agents; Benserazide; Benzophenones; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Time Factors; Tolcapone; Tyrosine	1999
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease. Neurology, 1975, Volume: 25, Issue:10 Topics: Adult; Aged; Arrhythmias, Cardiac; Carbidopa; Cardiac Complexes, Premature; Cardiovascular System; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Tachycardia	1975
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial. Journal of neurology, 1975, Dec-02, Volume: 211, Issue:1 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Vomiting	1975
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism. Lancet (London, England), 1976, Aug-07, Volume: 2, Issue:7980 Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors	1976
Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study. Lancet (London, England), 1977, Feb-26, Volume: 1, Issue:8009 Topics: Administration, Oral; Aged; Benserazide; Clinical Trials as Topic; Disability Evaluation; Drug Combinations; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrazines; Injections, Intravenous; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease; Phenethylamines; Time Factors	1977
Comparison of levodopa with carbidopa or benserazide in parkinsonism. Lancet (London, England), 1976, Aug-21, Volume: 2, Issue:7982 Topics: Aged; Benserazide; Carbidopa; Consumer Behavior; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
[Levodopa and decarboxylase inhibitors in Parkinson's disease]. Lakartidningen, 1977, Jan-05, Volume: 74, Issue:1-2 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting	1977
[Effect of MK-486 alone on Parkinsonism; studies on the clinical symptoms and catecholamine concentrations in the blood, urine and cerebrospinal fluid]. No to shinkei = Brain and nerve, 1977, Volume: 29, Issue:2 Topics: Aged; Carbidopa; Catecholamines; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Female; Homovanillic Acid; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1977
Amantadine and a fixed combination of levodopa and carbidopa in the treatment of Parkinson's disease. Diseases of the nervous system, 1977, Volume: 38, Issue:8 Topics: Adult; Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1977
Long-term treatment of Parkinson's disease with L-Dopa and Dopa-decarboxylase inhibitor: therapeutic results and side effects. Acta neurologica Scandinavica, 1978, Volume: 57, Issue:2 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1978
A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease. Annals of neurology, 1978, Volume: 3, Issue:3 Topics: Adult; Benserazide; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting	1978
Treatment of parkinsonism with N-n-propyl norapomorphine and levodopa (with or without carbidopa). Archives of neurology, 1978, Volume: 35, Issue:12 Topics: Aged; Apomorphine; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1978
A comparative clinical investigation of the therapeutic effect of levodopa alone and in combination with a decarboxylase inhibitor (carbidopa) in cases of Parkinson's disease. Current medical research and opinion, 1978, Volume: 5, Issue:9 Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Electrocardiography; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1978
Effect of a slow release preparation of levodopa on Parkinson's disease in combination with a peripheral decarboxylase inhibitor. Acta neurologica Scandinavica, 1978, Volume: 58, Issue:6 Topics: Adult; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1978
Levodopa/benserazide ('Madopar') combination therapy in elderly patients with parkinsonism. Current medical research and opinion, 1979, Volume: 6, Issue:1 Topics: Activities of Daily Living; Aged; Benserazide; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1979
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)]. Wiener klinische Wochenschrift, 1979, May-11, Volume: 91, Issue:10 Topics: Aged; Benserazide; Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1979
Levodopa with benserazide or carbidopa in Parkinson disease. Neurology, 1979, Volume: 29, Issue:12 Topics: Benserazide; Biological Availability; Carbidopa; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1979
[The clinical experience with the decarboxylase-blocked levodopa (Nacom) in the Parkinsonism patients]. ZFA. Zeitschrift fur Allgemeinmedizin, 1976, Mar-10, Volume: 52, Issue:7 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial. Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3 Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1976
Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report. Current therapeutic research, clinical and experimental, 1976, Volume: 19, Issue:3 Topics: Aged; Amantadine; Carbidopa; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
[Treatment of Parkinson's syndrome with L-dopa and L-carbidopa (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1976, May-14, Volume: 118, Issue:20 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease; Pyridoxine	1976
Madopar versus sinemet. A clinical study on their effectiveness. European neurology, 1975, Volume: 13, Issue:2 Topics: Adult; Aged; Benserazide; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Serine	1975
Alpha methyldopahydrazine as an adjunct to levodopa therapy in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1975, Volume: 2, Issue:3 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors	1975
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease. Neurology, 1975, Volume: 25, Issue:10 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Mental Disorders; Middle Aged; Movement Disorders; Parkinson Disease	1975
The effects of combining carbidopa with levodopa for Parkinson's disease. Geriatrics, 1975, Volume: 30, Issue:12 Topics: Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease; Vomiting	1975
L-dopa and carbidopa (sinemet) in the management of parkinsonism. Postgraduate medical journal, 1975, Volume: 51, Issue:599 Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis	1975
Treatment of "on-off effect" with a dopa decarboxylase inhibitor. Archives of neurology, 1975, Volume: 32, Issue:8 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1975
Parkinson's disease treated with Sinemet or Madopar. A controlled multicenter trial. Acta neurologica Scandinavica, 1976, Volume: 53, Issue:5 Topics: Aged; Benserazide; Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
Controlled-release levodopa/benserazide (Madopar HBS): clinical observations and levodopa and dopamine plasma concentrations in fluctuating parkinsonian patients. Journal of neurology, 1990, Volume: 237, Issue:1 Topics: Aged; Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Delayed-Action Preparations; Dopamine; Drug Combinations; Female; Follow-Up Studies; Hospitalization; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1990
A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in late Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Benserazide; Carboxy-Lyases; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Motor Skills; Multicenter Studies as Topic; Neurologic Examination; Parkinson Disease	1990
A comparison of Madopar CR and standard Madopar in the treatment of nocturnal and early-morning disability in Parkinson's disease. The U.K. Madopar CR Study Group. Clinical neuropharmacology, 1989, Volume: 12, Issue:6 Topics: Activities of Daily Living; Aged; Benserazide; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Parkinson Disease; Randomized Controlled Trials as Topic	1989
A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: Administration, Oral; Benserazide; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Ergolines; Humans; Hydrazines; Infusion Pumps; Levodopa; Lisuride; Parkinson Disease; Severity of Illness Index	1988
A controlled release form of madopar in parkinsonian patients with advanced disease and marked fluctuations in motor performance. Acta neurologica Scandinavica, 1988, Volume: 77, Issue:5 Topics: Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Humans; Hydrazines; Levodopa; Middle Aged; Movement; Parkinson Disease	1988
Madopar HBS in fluctuating parkinsonian patients: two-year treatment. Movement disorders : official journal of the Movement Disorder Society, 1988, Volume: 3, Issue:1 Topics: Adult; Aged; Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1988
The effect of R-(-)-deprenyl in de novo Parkinson patients on combination therapy with levodopa and decarboxylase inhibitor. Journal of neural transmission. Supplementum, 1987, Volume: 25 Topics: Benserazide; Clinical Trials as Topic; Disability Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Phenethylamines; Selegiline	1987
Clinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy. European neurology, 1987, Volume: 27 Suppl 1 Topics: Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1987
Open study of Madopar HBS, a new formulation of levodopa with benserazide, in 13 patients with Parkinson's disease and 'on-off' fluctuations. European neurology, 1987, Volume: 27 Suppl 1 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease. European neurology, 1987, Volume: 27 Suppl 1 Topics: Administration, Oral; Adult; Aged; Benserazide; Biological Availability; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Random Allocation	1987
Open clinical study of Madopar HBS. European neurology, 1987, Volume: 27 Suppl 1 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Infant, Newborn; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Treatment of parkinsonian conditions with a controlled-release form of levodopa--preliminary study. European neurology, 1987, Volume: 27 Suppl 1 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Preliminary experience with Madopar HBS: clinical observations and plasma levodopa concentrations. European neurology, 1987, Volume: 27 Suppl 1 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Clinical and pharmacokinetic observations with Madopar HBS in hospitalized patients with Parkinson's disease and motor fluctuations. European neurology, 1987, Volume: 27 Suppl 1 Topics: Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Hospitalization; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Open multicenter trial with Madopar HBS in parkinsonian patients. Preliminary assessment after short-term treatment. European neurology, 1987, Volume: 27 Suppl 1 Topics: Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1987
[Controlled release levodopa-benserazide and changes in efficacy during treatment of Parkinson's disease]. Revue neurologique, 1987, Volume: 143, Issue:11 Topics: Adult; Aged; Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1987
Single-dose study of slow release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Administration, Oral; Aged; Benserazide; Clinical Trials as Topic; Delayed-Action Preparations; Disability Evaluation; Drug Combinations; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Random Allocation	1987
Changes in taste under L-DOPA therapy. Zeitschrift fur Neurologie, 1971, Volume: 200, Issue:4 Topics: Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hydrazines; Parkinson Disease; Taste; Taste Disorders	1971
Methyldopa or methyldopahydrazine as levodopa synergists. Lancet (London, England), 1973, Jun-02, Volume: 1, Issue:7814 Topics: Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Humans; Hydrazines; Methyldopa; Parkinson Disease	1973
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone. Lancet (London, England), 1973, Dec-29, Volume: 2, Issue:7844 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrazines; Nausea; Parkinson Disease; Placebos; Time Factors; Vomiting	1973
[10 years of L-DOPA therapy of Parkinson's syndrome]. Wiener klinische Wochenschrift, 1971, Apr-02, Volume: 83, Issue:13 Topics: Administration, Oral; Amphetamine; Animals; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Cognition Disorders; Constipation; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Feeding and Eating Disorders; Hallucinations; Humans; Huntington Disease; Hydrazines; Hypertension; Infusions, Parenteral; Injections, Intravenous; Monoamine Oxidase Inhibitors; Movement Disorders; Nausea; Norepinephrine; Parkinson Disease; Serotonin; Stimulation, Chemical; Time Factors; Tremor; Vomiting	1971
[2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)]. Wiener medizinische Wochenschrift (1946), 1974, Jun-01, Volume: 124, Issue:22 Topics: Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Dermatitis, Seborrheic; Dihydroxyphenylalanine; Drug Combinations; Drug Evaluation; Humans; Hydrazines; Movement Disorders; Muscle Rigidity; Parkinson Disease; Speech Disorders; Tremor	1974
L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. Australian and New Zealand journal of medicine, 1974, Volume: 4, Issue:4 Topics: Aged; Blood Pressure; Carbidopa; Clinical Trials as Topic; Depression, Chemical; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos; Posture; Vomiting	1974
Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor. The New England journal of medicine, 1972, Jan-06, Volume: 286, Issue:1 Topics: Administration, Oral; Adult; Biotransformation; Brain; Carbon Monoxide Poisoning; Cerebral Palsy; Child; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Methyldopa; Neurologic Examination; Neuromuscular Diseases; Parkinson Disease; Phenylacetates; Pyridoxine; Time Factors	1972
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase. Journal of the neurological sciences, 1972, Volume: 17, Issue:1 Topics: Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Hydrazines; Male; Methyldopa; Movement Disorders; Parkinson Disease	1972
Parkinson's disease. Modification by 5-hydroxytryptophan. Neurology, 1972, Volume: 22, Issue:5 Topics: 5-Hydroxytryptophan; Adult; Aged; Brain; Carboxy-Lyases; Clinical Trials as Topic; Drug Synergism; Evaluation Studies as Topic; Extrapyramidal Tracts; Female; Humans; Hydrazines; Hydroxyindoleacetic Acid; Male; Methyldopa; Middle Aged; Parkinson Disease; Phenylacetates; Placebos; Serotonin	1972
[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor]. Fortschritte der Neurologie, Psychiatrie, und ihrer Grenzgebiete, 1972, Volume: 40, Issue:10 Topics: Adult; Aged; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combinations; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1972
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)]. Wiener medizinische Wochenschrift (1946), 1973, Jun-30, Volume: 123, Issue:26 Topics: Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combinations; Evaluation Studies as Topic; Gastrointestinal Diseases; Gymnastics; Humans; Hydrazines; Levodopa; Parkinson Disease; Speech Therapy	1973
Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy. New York state journal of medicine, 1974, Volume: 74, Issue:1 Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrazines; Methyldopa; Middle Aged; Parkinson Disease	1974
A double-blind controlled study of MK-486 in Parkinson's disease. Transactions of the American Neurological Association, 1973, Volume: 98 Topics: Aged; Anorexia Nervosa; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Parkinson Disease; Placebos	1973
Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. The Medical journal of Australia, 1974, Mar-23, Volume: 1, Issue:12 Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Placebos	1974
Sinemet. Drug and therapeutics bulletin, 1974, Oct-11, Volume: 12, Issue:21 Topics: Carbidopa; Clinical Trials as Topic; Drug Combinations; Humans; Hydrazines; Levodopa; Parkinson Disease	1974
Report on 45-month treatment of parkinsonism with L-dopa, alone and in association with a decarboxilase inhibitor (Ro 4-4602). Acta neurologica latinoamericana, 1974, Volume: 20, Issue:1-4 Topics: Adult; Aged; Benserazide; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Tablets	1974
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. British medical journal, 1971, Sep-25, Volume: 3, Issue:5777 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Hydrazines; Male; Methyldopa; Middle Aged; Nausea; Parkinson Disease; Vomiting	1971
Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa. British journal of pharmacology, 1972, Volume: 44, Issue:1 Topics: Adult; Aged; Blood Pressure; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrazines; Hypotension; Male; Methyldopa; Middle Aged; Parkinson Disease; Pulse	1972
Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism. Neurology, 1972, Volume: 22, Issue:4 Topics: Adolescent; Adult; Aged; Blood Pressure; Brain; Child; Dihydroxyphenylalanine; Dopamine; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Heart; Humans; Hydrazines; Hydroxyindoleacetic Acid; Male; Methyldopa; Middle Aged; Motor Skills; Parkinson Disease; Phenylacetates; Serotonin	1972

Other Studies

152 other study(ies) available for hydrazine and Parkinson Disease

Article	Year
Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system. Neuroscience letters, 2016, Mar-11, Volume: 616 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benserazide; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Hydrazines; Levodopa; Male; Mice, Inbred C57BL; Motor Activity; Neuroprotective Agents; Oxadiazoles; Oxidative Stress; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase	2016
[Combined (surgical and drug) therapy of parkinsonism]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1984, Volume: 84, Issue:8 Topics: Benserazide; Catecholamines; Combined Modality Therapy; Diencephalon; Drug Combinations; Humans; Hydrazines; Levodopa; Parkinson Disease; Stereotaxic Techniques	1984
Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism. Neurology, 1984, Volume: 34, Issue:12 Topics: Animals; Behavior, Animal; Corpus Striatum; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Hydrazines; Levodopa; Male; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra	1984
Combined use of benserazide and carbidopa in Parkinson's disease. Neurology, 1984, Volume: 34, Issue:2 Topics: Adult; Aged; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Outcome and Process Assessment, Health Care; Parkinson Disease	1984
Response to Sinemet 25/100 in Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Aged; Benserazide; Body Weight; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors	1984
[Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1980, Volume: 13, Issue:4 Topics: Aged; Benserazide; Drug Combinations; Electromyography; Female; Homovanillic Acid; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Phenylacetates; Thyrotropin; Thyrotropin-Releasing Hormone	1980
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels. Journal of neural transmission, 1982, Volume: 53, Issue:1 Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; Hydrazines; Middle Aged; Parkinson Disease; Schizophrenia; Tryptophan	1982
Improved control of brittle Parkinsonism by separate administration of levodopa and benserazide. British medical journal (Clinical research ed.), 1982, Apr-03, Volume: 284, Issue:6321 Topics: Benserazide; Drug Administration Schedule; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Time Factors	1982
Thyrotrophin and prolactin responses to thyrotrophin-releasing hormone in patients with Parkinson's disease. Acta endocrinologica, 1982, Volume: 99, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine	1982
Prolactin response to acute administration of different L-dopa plus decarboxylase inhibitors in Parkinson's disease. Neuropsychobiology, 1982, Volume: 8, Issue:2 Topics: Aged; Animals; Benserazide; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Rats	1982
Growth hormone and prolactin stimulation by Madopar in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1981, Volume: 44, Issue:12 Topics: Adult; Aged; Antiparkinson Agents; Benserazide; Drug Combinations; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Prolactin; Receptors, Dopamine	1981
[Madopar in the treatment of paralysis agitans. I. Therapeutic efficacy and side-effects in 56 cases (author's transl)]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1980, Volume: 13, Issue:3 Topics: Adult; Benserazide; Electrocardiography; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease	1980
Benserazide and carbidopa as substrates of catechol-O-methyltransferase: new mechanism of action in Parkinson's disease. Biochemical pharmacology, 1980, Dec-01, Volume: 29, Issue:23 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Benzyl Compounds; Carbidopa; Catechol O-Methyltransferase; Hydrazines; Kinetics; Liver; Parkinson Disease; S-Adenosylmethionine; Substrate Specificity; Swine	1980
Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease. Journal of neurochemistry, 2001, Volume: 79, Issue:6 Topics: Alkaloids; Aminoquinolines; Animals; Antioxidants; Apoptosis; Ascorbic Acid; Buthionine Sulfoximine; Carbazoles; Cell Division; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Dopamine; Enzyme Inhibitors; Free Radicals; Glutathione; Glutathione Synthase; Guanylate Cyclase; Homeostasis; Hydrazines; Indoles; Mesencephalon; Methylene Blue; Nerve Tissue Proteins; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Nucleic Acid Synthesis Inhibitors; Parkinson Disease; Penicillamine; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase	2001
Drug therapy for Parkinsonism. Modern healthcare. [Short-term care ed.], 1976, Volume: 5, Issue:1 Topics: Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Parkinson Disease	1976
Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa. Lancet (London, England), 1976, Sep-11, Volume: 2, Issue:7985 Topics: Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia, Paranoid	1976
Pharmaceutical review: salbutamol - madopar - isocal. The Lamp, 1978, Volume: 35, Issue:3 Topics: Albuterol; Australia; Benserazide; Humans; Hydrazines; Levodopa; Lung Diseases; Parenteral Nutrition; Parkinson Disease	1978
[Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, HCL-benserazide, on Parkinson's disease-part I: clinical aspects (author's transl)]. No to shinkei = Brain and nerve, 1979, Volume: 31, Issue:3 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Pressure; Dopa Decarboxylase; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1979
Electroencephalographic change in Parkinsonian patients treated with levodopa-carbidopa. Clinical EEG (electroencephalography), 1979, Volume: 10, Issue:1 Topics: Aged; Carbidopa; Drug Therapy, Combination; Electroencephalography; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1979
Causes of pseudotumor cerebri and papilledema. Archives of internal medicine, 1979, Volume: 139, Issue:7 Topics: Aged; Carbidopa; Dose-Response Relationship, Drug; Female; Humans; Hydrazines; Levodopa; Papilledema; Parkinson Disease; Pseudotumor Cerebri	1979
[Comparative studies of L-DOPA alone and combination with a peripheral DOPA decarboxylase inhibitor, benserazide-HCl, on Parkinson's disease--Part II: Pharmacokinetic study (author's transl)]. No to shinkei = Brain and nerve, 1979, Volume: 31, Issue:4 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Drug Therapy, Combination; Female; Humans; Hydrazines; Kinetics; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1979
Reversible haemolytic anaemia after levodopa-carbidopa. British medical journal, 1979, Jun-02, Volume: 1, Issue:6176 Topics: Aged; Anemia, Hemolytic, Autoimmune; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Parkinson Disease	1979
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa. Clinical science (London, England : 1979), 1979, Volume: 56, Issue:1 Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan	1979
["Immune type" haemolysis in course of L. dopa-benserazide therapeutic (author's transl)]. La Nouvelle presse medicale, 1979, Jan-06, Volume: 8, Issue:1 Topics: Aged; Anemia, Hemolytic, Autoimmune; Benserazide; Coombs Test; Female; Humans; Hydrazines; Levodopa; Parkinson Disease	1979
Comparative effectiveness of two extracerebral DOPA decarboxylase inhibitors in Parkinson disease. Neurology, 1978, Volume: 28, Issue:9 Pt 1 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1978
Need for uncombined carbidopa to treat parkinsonism. Neurology, 1978, Volume: 28, Issue:10 Topics: Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease	1978
Sinemet and thyroid function in Parkinson disease. Neurology, 1979, Volume: 29, Issue:7 Topics: Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Male; Parkinson Disease; Thyroid Function Tests; Thyroid Gland; Thyrotropin	1979
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12 Topics: Aged; Benserazide; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1977
Application of paired-ion high-pressure liquid column chromatography to the analysis of L-3,4-dihydroxyphenylalanine metabolites. Journal of chromatography, 1978, Mar-01, Volume: 145, Issue:2 Topics: Carbidopa; Chromatography, High Pressure Liquid; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Parkinson Disease	1978
Paradoxial response to dopaminergic agents in parkinsonism. Archives of neurology, 1978, Volume: 35, Issue:7 Topics: Acetonitriles; Aged; Carbidopa; Ergolines; Homovanillic Acid; Humans; Hydrazines; Levodopa; Male; Parkinson Disease; Receptors, Dopamine	1978
[Long-term syndrome in the treatment of parkinsonism with L-dopa and decarboxylase an inhibitor]. Neurologia, neurocirugia, psiquiatria, 1976, Volume: 17, Issue:4 Topics: Adult; Benserazide; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease	1976
The long-term effects of combining carbidopa with levodopa for Parkinson's disease. Transactions of the American Neurological Association, 1976, Volume: 101 Topics: Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Parkinson Disease	1976
Drug therapy of Parkinsonism dopaminergic drugs. The Ohio State medical journal, 1977, Volume: 73, Issue:2 Topics: Carbidopa; Humans; Hydrazines; Levodopa; Parkinson Disease	1977
The clinical picture and plasma levodopa metabolite profile of parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor. Archives of neurology, 1977, Volume: 34, Issue:4 Topics: Adult; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1977
[Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study]. Schweizerische medizinische Wochenschrift, 1977, Apr-09, Volume: 107, Issue:14 Topics: Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Parkinson Disease; Psychoses, Substance-Induced	1977
Effect of L-dopa on polycythemia. Journal of the American Geriatrics Society, 1977, Volume: 25, Issue:5 Topics: Aged; Benserazide; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Polycythemia Vera	1977
Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602. European journal of clinical pharmacology, 1977, Apr-20, Volume: 11, Issue:4 Topics: Benserazide; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Middle Aged; Parkinson Disease; Phenylacetates; Time Factors	1977
["Beginning and end of dose" dyskinesias caused by L-DOPA]. Revue neurologique, 1977, Volume: 133, Issue:5 Topics: Benserazide; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1977
Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline. British medical journal, 1977, Sep-03, Volume: 2, Issue:6087 Topics: Acute Disease; Amitriptyline; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypertension; Levodopa; Metoclopramide; Middle Aged; Parkinson Disease	1977
[Treatment of Parkinson's syndrome with a combination of levodopa and carbidopa]. Archivos de investigacion medica, 1977, Volume: 8, Issue:2 Topics: Adult; Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1977
Six-year results of treatment with levodopa plus benzerazide in Parkinson's disease. Neurology, 1976, Volume: 26, Issue:5 Topics: Adult; Aged; Benserazide; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Patient Dropouts; Time Factors	1976
Psychiatric symptoms with initiation of carbidopa-levodopa treatment. Neurology, 1976, Volume: 26, Issue:7 Topics: Aged; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced	1976
Letter: Carbidopa. JAMA, 1976, Jan-12, Volume: 235, Issue:2 Topics: Carbidopa; Humans; Hydrazines; Parkinson Disease; United States	1976
Mortality among Parkinson patients treated with L-dopa combined with a decarboxylase inhibitor. European neurology, 1976, Volume: 14, Issue:5 Topics: Adult; Aged; Benserazide; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies; Switzerland	1976
In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration. Journal of neural transmission, 1976, Volume: 38, Issue:3-4 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Carbidopa; Dopamine; Drug Interactions; Humans; Hydrazines; Levodopa; Parkinson Disease; Pyridoxine; Rats	1976
Study of deterioration in long-term treatment of parkinsonism with L-dopa plus decarboxylase inhibitor. Journal of neural transmission, 1976, Volume: 38, Issue:3-4 Topics: Benserazide; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors	1976
[Carbidopa-levodopa, growth hormone and parkinsonism]. Revista clinica espanola, 1976, Jun-30, Volume: 141, Issue:6 Topics: Aged; Carbidopa; Female; Growth Hormone; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Stimulation, Chemical	1976
[Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine]. Rinsho shinkeigaku = Clinical neurology, 1976, Jul-01, Volume: 16, Issue:7 Topics: Adult; Aged; Benserazide; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
[5 years of experience in the treatment of parkinsonism with L-dopa and its combination with Ro4-4602]. Neurologia, neurocirugia, psiquiatria, 1976, Volume: 17, Issue:4 Topics: Adult; Aged; Benserazide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
[Treatment of Parkinson's disease with levodopa and a dopa decarboxylase inhibitor]. Neurologia, neurocirugia, psiquiatria, 1976, Volume: 17, Issue:4 Topics: Adult; Aged; Carbidopa; Drug Combinations; Drug Evaluation; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Tablets	1976
[Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor]. Rinsho shinkeigaku = Clinical neurology, 1976, Volume: 16, Issue:12 Topics: Adult; Aged; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease	1976
Dopaminergic supersensitivity in parkinsonism. Advances in neurology, 1975, Volume: 9 Topics: Aged; Benzyl Compounds; Brain; Brain Chemistry; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Nerve Degeneration; Norepinephrine; Parkinson Disease; Psychoses, Substance-Induced; Serotonin; Tryptophan; Tyrosine	1975
Abnormal involuntary movements in relation to anticholinergics and levodopa therapy. Acta neurologica Scandinavica, 1975, Volume: 52, Issue:2 Topics: Benserazide; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parasympatholytics; Parkinson Disease	1975
L-dopa therapy combined with peripheral decarboxylase inhibitor (MK-486) in Parkinsonism. Folia psychiatrica et neurologica japonica, 1975, Volume: 29, Issue:1 Topics: Adult; Aged; Animals; Carbidopa; Carboxy-Lyases; Cats; Dopamine; Drug Therapy, Combination; Female; Humans; Hydrazines; Injections, Intraperitoneal; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1975
[Treatment of Parkinson's syndromes by a combination of levodopa with decarboxylase inhibitors]. Ceskoslovenska neurologie a neurochirurgie, 1975, Volume: 38, Issue:6 Topics: Adult; Aged; Carbidopa; Carboxy-Lyases; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1975
Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations. Clinical neurology and neurosurgery, 1975, Volume: 78, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Benserazide; Biogenic Amines; Dopamine; Female; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Metanephrine; Middle Aged; Normetanephrine; Parkinson Disease; Tyramine; Vanilmandelic Acid	1975
[Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism]. La Clinica terapeutica, 1975, Aug-15, Volume: 74, Issue:3 Topics: Carbidopa; Growth Hormone; Humans; Hydrazines; Levodopa; Parkinson Disease; Pituitary Gland; Stimulation, Chemical	1975
L-dopa-carbidopa: combined therapy for the treatment of Parkinson's disease. Diseases of the nervous system, 1976, Volume: 37, Issue:3 Topics: Adult; Aged; Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1976
[Experiences in the treatment of Parkinsonism using a combination of L-dopa and alpha-methyldopa-hydrazine]. Ceskoslovenska neurologie a neurochirurgie, 1976, Volume: 39, Issue:2 Topics: Adult; Aged; Drug Combinations; Drug Evaluation; Drug Synergism; Humans; Hydrazines; Levodopa; Methyldopa; Middle Aged; Parkinson Disease	1976
Letter: Alternatives to levodopa. British medical journal, 1976, Jun-05, Volume: 1, Issue:6022 Topics: Aged; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease	1976
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:3 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Carboxy-Lyases; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Hydrazines; Levodopa; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease	1990
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid. Acta neurologica Scandinavica. Supplementum, 1989, Volume: 126 Topics: Benserazide; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Glycols; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Parkinson Disease; Phenethylamines; Selegiline	1989
Treatment of early Parkinson's disease with controlled-release levodopa preparations. Neurology, 1989, Volume: 39, Issue:11 Suppl 2 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Parkinson Disease	1989
Enantiomeric composition of urinary salsolinol in parkinsonian patients after Madopar. Journal of neural transmission. Parkinson's disease and dementia section, 1989, Volume: 1, Issue:4 Topics: Aged; Aged, 80 and over; Benserazide; Drug Combinations; Female; Humans; Hydrazines; Isoquinolines; Levodopa; Male; Middle Aged; Parkinson Disease; Stereoisomerism	1989
[The concentration of homovanillic acid and leucine-enkephalin in the lumbar CSF of patients with Parkinson's disease before and after madopar treatment]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1989, Volume: 22, Issue:2 Topics: Adult; Aged; Benserazide; Carboxy-Lyases; Drug Combinations; Enkephalin, Leucine; Female; Homovanillic Acid; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1989
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine. European archives of psychiatry and neurological sciences, 1985, Volume: 235, Issue:1 Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan	1985
Optimization of symptomatic therapy in Parkinson's disease. IEEE transactions on bio-medical engineering, 1989, Volume: 36, Issue:3 Topics: Benserazide; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Computer-Assisted; Humans; Hydrazines; Levodopa; Models, Biological; Parkinson Disease; Reaction Time; Therapy, Computer-Assisted	1989
[An open study of a new formulation of the levodopa and benserazide combination in the treatment of fluctuations of motor performance in patients with Parkinson's disease]. La Clinica terapeutica, 1988, Apr-30, Volume: 125, Issue:2 Topics: Aged; Benserazide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1988
MPTP: clinical implications. Journal of neural transmission. Supplementum, 1986, Volume: 20 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Basal Ganglia; Benserazide; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease; Phenethylamines; Pyridines; Selegiline	1986
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy. Pharmatherapeutica, 1986, Volume: 4, Issue:9 Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease	1986
Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience. Journal of neural transmission. Supplementum, 1986, Volume: 22 Topics: Benserazide; Drug Combinations; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease; Phenethylamines; Retrospective Studies; Selegiline; Time Factors	1986
(-)Deprenyl in the treatment of decompensated Parkinson's disease. Journal of neural transmission. Supplementum, 1986, Volume: 22 Topics: Benserazide; Drug Combinations; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline	1986
Madopar HBS in Parkinson patients with nocturnal akinesia. Clinical neurology and neurosurgery, 1988, Volume: 90, Issue:1 Topics: Adult; Aged; Benserazide; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1988
Madopar HBS. International workshop on the 'on-off-phenomenon in Parkinson's disease. New possibilities for its management. Agno, November 14-16, 1985. European neurology, 1987, Volume: 27 Suppl 1 Topics: Benserazide; Drug Combinations; Humans; Hydrazines; Levodopa; Parkinson Disease	1987
Madopar HBS in the long-term treatment of parkinsonian patients with fluctuations in disability. European neurology, 1987, Volume: 27 Suppl 1 Topics: Aged; Benserazide; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1987
A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease. European neurology, 1987, Volume: 27 Suppl 1 Topics: Benserazide; Circadian Rhythm; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Substitution of standard Madopar by Madopar HBS in parkinsonians with fluctuations. European neurology, 1987, Volume: 27 Suppl 1 Topics: Aged; Aged, 80 and over; Benserazide; Biological Availability; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Madopar HBS: slow-release levodopa and benserazide in parkinsonian patients presenting marked fluctuations in symptoms on standard L-dopa treatment. European neurology, 1987, Volume: 27 Suppl 1 Topics: Adult; Aged; Benserazide; Delayed-Action Preparations; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Therapeutic value of Madopar HBS: judgment after 2 years experience. European neurology, 1987, Volume: 27 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Benserazide; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease	1987
Monoamine oxidase B, smoking, and Parkinson's disease. Journal of the neurological sciences, 1986, Volume: 72, Issue:2-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blood Platelets; Brain; Humans; Hydrazines; Isoenzymes; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Nicotine; Parkinson Disease; Pyridines; Smoking; Thiocyanates	1986
Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition. Acta neurologica Scandinavica, 1985, Volume: 71, Issue:1 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Autonomic Nervous System; Benserazide; Blood Pressure; Carbidopa; Drug Therapy, Combination; Female; Heart; Heart Rate; Humans; Hydrazines; Levodopa; Male; Middle Aged; Muscle Contraction; Parkinson Disease	1985
Inhibitory effect of drugs used in the treatment of Parkinson's disease on plasma monoamine oxidase activity. Journal of neural transmission, 1985, Volume: 61, Issue:3-4 Topics: Adult; Aged; Benserazide; Benzylamine Oxidase; Carbidopa; Female; Humans; Hydrazines; Isoenzymes; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease	1985
[Clinical significance of cramps of the lower extremities in patients with parkinsonism]. Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry, 1985, Volume: 18, Issue:4 Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Leg; Levodopa; Male; Middle Aged; Muscle Cramp; Parkinson Disease	1985
Levadopa and psoriasis. Lancet (London, England), 1972, Jan-22, Volume: 1, Issue:7743 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benzyl Compounds; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Parkinson Disease; Psoriasis; Serine	1972
Levodopa and Ro 4-4602 in psoriasis. Lancet (London, England), 1972, Aug-12, Volume: 2, Issue:7772 Topics: Adolescent; Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benzyl Compounds; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Psoriasis; Serine	1972
Treatment of Parkinson's disease with L-DOPA and an association L-DOPA plus a DOPA decarboxylase inhibitor. Zeitschrift fur Neurologie, 1972, Volume: 202, Issue:4 Topics: Administration, Oral; Dihydroxyphenylalanine; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Hydrazines; Hypotension; Male; Parkinson Disease	1972
Dopa-decarboxylase inhibitors. Lancet (London, England), 1973, May-05, Volume: 1, Issue:7810 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dihydroxyphenylalanine; Dopamine; Humans; Hydrazines; Parkinson Disease	1973
[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor]. Munchener medizinische Wochenschrift (1950), 1973, Apr-20, Volume: 115, Issue:16 Topics: Amino Acids; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Drug Combinations; Female; Humans; Hydrazines; Long-Term Care; Male; Middle Aged; Parkinson Disease	1973
[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)]. Archiv fur Psychiatrie und Nervenkrankheiten, 1967, Aug-08, Volume: 210, Issue:1 Topics: Aged; Carboxy-Lyases; Catecholamines; Chorea; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; NAD; Oxidoreductases; Parkinson Disease; Phenylalanine; Tyrosine	1967
A neuropsychopharmacological comparison of d-amphetamine, L-dopa and cocaine. Neuropharmacology, 1971, Volume: 10, Issue:6 Topics: Animals; Behavior, Animal; Cats; Cocaine; Cortical Synchronization; Dextroamphetamine; Dihydroxyphenylalanine; Electroencephalography; Female; Hair; Humans; Hydrazines; Male; Methyldopa; Paranoid Disorders; Parkinson Disease; Phenethylamines; Reticular Formation; Salivation; Sleep, REM; Stereoisomerism	1971
A reliable and simple method for simultaneous determination of DOPA and 3-O-methyldopa in plasma and brain. Analytical biochemistry, 1972, Volume: 46, Issue:2 Topics: Antiparkinson Agents; Brain Chemistry; Carbon Isotopes; Chromatography, Ion Exchange; Cold Temperature; Dihydroxyphenylalanine; Edetic Acid; Epinephrine; Ferricyanides; Humans; Hydrazines; Hydrogen-Ion Concentration; Iodine; Methods; Methyldopa; Norepinephrine; Oxidation-Reduction; Parkinson Disease; Perchlorates; Periodic Acid; Spectrometry, Fluorescence	1972
Actions of levodopa and dopamine in the central nervous system. JAMA, 1971, Dec-27, Volume: 218, Issue:13 Topics: Animals; Apomorphine; Binding Sites; Brain; Central Nervous System; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Haplorhini; Hydrazines; Methyltyrosines; Neurotransmitter Agents; Parkinson Disease; Rabbits; Rats; Receptors, Cholinergic; Receptors, Neurotransmitter; Reserpine; Substantia Nigra; Synapses; Synaptic Transmission	1971
Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. The Journal of pharmacy and pharmacology, 1972, Volume: 24, Issue:4 Topics: Amino Acids; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia; Brain Chemistry; Carbon Isotopes; Carboxylic Acids; Catecholamines; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrazines; Hypothalamus; Male; Myocardium; Parkinson Disease; Propionates; Rats	1972
[Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease]. La Revue du praticien, 1974, Mar-11, Volume: 24, Issue:15 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Benzyl Compounds; Carbidopa; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Parkinson Disease; Phenols	1974
[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor]. Archivos de investigacion medica, 1974, Volume: 5, Issue:2 Topics: Adult; Aged; Benserazide; Capsules; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; Drug Evaluation; Drug Synergism; Enzyme Inhibitors; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1974
[Treatment of parkinsonism by L-dopa and dopa-decarboxylase inhibitor in a single tablet]. Harefuah, 1974, Sep-01, Volume: 87, Issue:5 Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Drug Combinations; Humans; Hydrazines; Levodopa; Parkinson Disease	1974
Short- and long-term approaches to the "on-off" phenomenon. Advances in neurology, 1974, Volume: 5 Topics: Apomorphine; Carbidopa; Dietary Proteins; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Movement Disorders; Parkinson Disease; Time Factors	1974
[The association of L-DOPA and Ro 4-4602 in the treatment of Parkinson's disease (author's transl)]. Rivista di patologia nervosa e mentale, 1974, Volume: 95, Issue:5 Topics: Benserazide; Drug Combinations; Drug Evaluation; Humans; Hydrazines; Levodopa; Parkinson Disease	1974
[Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)]. Rivista di patologia nervosa e mentale, 1974, Volume: 95, Issue:5 Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Mental Processes; Parkinson Disease; Psychological Tests	1974
Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study. Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Ankle Joint; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Drug Combinations; Electromyography; Humans; Hydrazines; Movement; Muscle Contraction; Muscle Tonus; Parkinson Disease; Reflex; Time Factors	1972
Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone). Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Administration, Oral; Aromatic Amino Acid Decarboxylase Inhibitors; Capsules; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hydrazines; Movement Disorders; Nausea; Parkinson Disease; Retrospective Studies; Time Factors; Vomiting	1972
Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602). Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Administration, Oral; Aromatic Amino Acid Decarboxylase Inhibitors; Capsules; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Time Factors	1972
Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor. Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Drug Combinations; Follow-Up Studies; Humans; Hydrazines; Libido; Male; Parkinson Disease; Stimulation, Chemical; Testosterone; Time Factors	1972
Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa. The Medical annals of the District of Columbia, 1974, Volume: 43, Issue:12 Topics: Aged; Carbidopa; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease	1974
[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism]. Wiener medizinische Wochenschrift (1946), 1972, Jun-17, Volume: 122, Issue:25 Topics: Administration, Oral; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Dopa Decarboxylase; Drug Combinations; Drug Therapy; History, 19th Century; History, 20th Century; Humans; Hydrazines; Parkinson Disease	1972
[Quantitative rigor determination in Parkinson's disease. Myo-integration for therapy control of L-Dopa in combination with a decarboxylase inhibitor (Ro 8-0576)]. Der Nervenarzt, 1974, Volume: 45, Issue:2 Topics: Aged; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Evaluation; Electromyography; Humans; Hydrazines; Middle Aged; Muscle Rigidity; Muscle Tonus; Parkinson Disease; Stereotaxic Techniques	1974
[Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study]. Der Nervenarzt, 1972, Volume: 43, Issue:10 Topics: Adult; Aged; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Hydrazines; Long-Term Care; Male; Middle Aged; Nausea; Parkinson Disease; Time Factors; Vomiting	1972
The balance of biogenic amines as condition for normal behaviour. Journal of neural transmission, 1972, Volume: 33, Issue:2 Topics: Aged; Benzyl Compounds; Brain; Dihydroxyphenylalanine; Dopamine; Electroencephalography; Female; Humans; Hydrazines; Hydroxyindoleacetic Acid; Male; Middle Aged; Norepinephrine; Parkinson Disease; Phenylacetates; Psychoses, Substance-Induced; Serine; Serotonin; Tryptophan	1972
The action of L(-)-dopa on baroreflexes in Parkinsonism. Clinical science, 1972, Volume: 43, Issue:6 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Pressure; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Methyldopa; Middle Aged; Parkinson Disease; Posture; Pressoreceptors; Reflex; Valsalva Maneuver	1972
[Therapy of parkinsonism using L-dopa. I]. Zeitschrift fur arztliche Fortbildung, 1972, Dec-01, Volume: 66, Issue:23 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Hydrazines; Monoamine Oxidase Inhibitors; Parkinson Disease	1972
[Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor]. Harefuah, 1972, Nov-01, Volume: 83, Issue:9 Topics: Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; Humans; Hydrazines; Parkinson Disease; Time Factors	1972
Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor. Archives of neurology, 1973, Volume: 28, Issue:2 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia; Brain; Brain Chemistry; Caudate Nucleus; Cerebellar Cortex; Cerebral Cortex; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrazines; Hypothalamus; Male; Middle Aged; Norepinephrine; Palladium; Parkinson Disease; Phenylacetates; Substantia Nigra; Thalamus	1973
Modification of levodopa effect by systemic decarboxylase inhibition. Archives of neurology, 1973, Volume: 28, Issue:2 Topics: Arrhythmias, Cardiac; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Electrocardiography; Humans; Hydrazines; Methyldopa; Parkinson Disease	1973
[Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study]. La Nouvelle presse medicale, 1973, Feb-03, Volume: 2, Issue:5 Topics: Benzyl Compounds; Carboxy-Lyases; Depression; Dihydroxyphenylalanine; Drug Combinations; Humans; Hydrazines; Movement Disorders; Parkinson Disease; Serotonin	1973
Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase. Journal of neurology, neurosurgery, and psychiatry, 1973, Volume: 36, Issue:1 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1973
[Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease]. Archiv fur Psychiatrie und Nervenkrankheiten, 1973, Mar-19, Volume: 217, Issue:1 Topics: Aged; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Female; Gastrointestinal Diseases; Humans; Hydrazines; Hypotension; Male; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors	1973
Levodopa and related drugs. The Medical letter on drugs and therapeutics, 1973, Mar-02, Volume: 15, Issue:5 Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Pyridoxine	1973
Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor. European neurology, 1973, Volume: 9, Issue:6 Topics: Adult; Aged; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Libido; Male; Middle Aged; Parkinson Disease; Phenylacetates; Probenecid; Serotonin	1973
L-Dopa, B 6 , and alpha-methyldopa hydrazine. Confinia neurologica, 1973, Volume: 35, Issue:3 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Carbidopa; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Pyridoxine	1973
An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy. Journal of neurology, neurosurgery, and psychiatry, 1973, Volume: 36, Issue:3 Topics: Aged; Carbidopa; Diagnosis, Differential; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Male; Muscle Rigidity; Muscles; Neurologic Examination; Parkinson Disease; Tremor	1973
L-dopa level in plasma, primary condition for the kinetic effect. Journal of neural transmission, 1973, Volume: 34, Issue:2 Topics: Administration, Oral; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Biopharmaceutics; Brain; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Hydrazines; Injections, Intravenous; Male; Motor Activity; Parkinson Disease	1973
[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study]. Schweizerische medizinische Wochenschrift, 1973, Oct-20, Volume: 103, Issue:42 Topics: Aged; Benserazide; Carboxy-Lyases; Depression; Dihydroxyphenylalanine; Drug Evaluation; Drug Therapy, Combination; Humans; Hydrazines; Methyldopa; Middle Aged; Paralysis; Parkinson Disease; Sleep Wake Disorders; Time Factors	1973
[Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation]. Revista medica de Chile, 1973, Volume: 101, Issue:6 Topics: Administration, Oral; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Synergism; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Hydrazines; Middle Aged; Parkinson Disease	1973
Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease. Transactions of the American Neurological Association, 1973, Volume: 98 Topics: Brain; Carbidopa; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Homovanillic Acid; Humans; Hydrazines; Parkinson Disease; Pyridoxine	1973
Plasma concentration of levodopa in patients with Parkinson's disease. European neurology, 1973, Volume: 10, Issue:5 Topics: Administration, Oral; Adult; Aged; Benserazide; Dihydroxyphenylalanine; Drug Combinations; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic	1973
[Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion]. Folia endocrinologica, 1973, Volume: 26, Issue:6 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Diencephalon; Dihydroxyphenylalanine; Drug Combinations; Female; Growth Hormone; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Pituitary Gland	1973
Bensarazid with L-dopa in the treatment of parkinson's disease. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1974, Feb-09, Volume: 48, Issue:6 Topics: Adult; Aged; Benserazide; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; L-Lactate Dehydrogenase; Male; Middle Aged; Parkinson Disease; Urea	1974
[Dopa and decarboxylase inhibitors in Parkinson's disease]. Ugeskrift for laeger, 1974, Feb-11, Volume: 136, Issue:7 Topics: Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Hydrazines; Parkinson Disease	1974
Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions. Archives of neurology, 1974, Volume: 30, Issue:6 Topics: Carbidopa; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Drug Interactions; Drug Synergism; Homovanillic Acid; Humans; Hydrazines; Parkinson Disease; Pyridoxine	1974
Carbidopa in Parkinson disease and in nausea and vomiting of levodopa. Archives of neurology, 1974, Volume: 31, Issue:2 Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Nausea; Parkinson Disease; Vomiting	1974
Pharmacokinetics of the decarboxylase inhibitor benserazide in man; its tissue distribution in the rat. European journal of clinical pharmacology, 1974, Volume: 7, Issue:1 Topics: Aged; Animals; Autoradiography; Benserazide; Brain; Carbon Radioisotopes; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Stability; Feces; Female; Gastric Juice; Humans; Hydrazines; Intestinal Absorption; Kidney; Liver; Male; Middle Aged; Myocardium; Parkinson Disease; Rats; Time Factors	1974
Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine. Neurology, 1974, Volume: 24, Issue:3 Topics: Adult; Aged; Carbidopa; Dementia; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Hydrazines; Male; Middle Aged; Pacific Islands; Parkinson Disease	1974
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology, 1974, Volume: 24, Issue:5 Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydrazines; Injections, Intramuscular; Male; Methyldopa; Middle Aged; Movement Disorders; Parkinson Disease; Pyridoxine	1974
Ro 4-4602 and levodopa in the treatment of Parkinsonism. Neurology, 1974, Volume: 24, Issue:5 Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia Diseases; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Gastrointestinal Diseases; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1974
[L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism]. Nihon rinsho. Japanese journal of clinical medicine, 1974, Volume: 32, Issue:3 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease	1974
Levodopa combined with peripheral decarboxylase inhibition in Parkinson's disease. Canadian Medical Association journal, 1972, Jun-10, Volume: 106, Issue:11 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Benzyl Compounds; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Hypotension; Middle Aged; Movement Disorders; Parkinson Disease; Serine; Vertigo	1972
[Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602]. Revue canadienne de biologie, 1972, Volume: 31 Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benzyl Compounds; Capsules; Dihydroxyphenylalanine; Humans; Hydrazines; Parkinson Disease; Serine; Time Factors	1972
Levadopa and pyridoxine. JAMA, 1972, Mar-27, Volume: 219, Issue:13 Topics: Animals; Brain; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Drug Interactions; Humans; Hydrazines; Injections, Intraperitoneal; Methyldopa; Mice; Parkinson Disease; Propionates; Pyridoxine	1972
On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients. Journal of neurochemistry, 1972, Volume: 19, Issue:9 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia; Benzyl Compounds; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Hydrazines; Male; Parkinson Disease; Pyridoxal Phosphate; Pyridoxine; Rats; Serine	1972
[Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase]. Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 33, Issue:1 Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Humans; Hydrazines; Hydrochloric Acid; Methyldopa; Parkinson Disease; Phenylacetates; Sodium Hydroxide	1971
[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association]. Wiener medizinische Wochenschrift (1946), 1971, Oct-16, Volume: 121, Issue:42 Topics: Aged; Benzyl Compounds; Carboxy-Lyases; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Middle Aged; Parkinson Disease; Serine; Speech Disorders; Tremor	1971
L-dopa and cardiac arrhythmias. The New England journal of medicine, 1971, Dec-16, Volume: 285, Issue:25 Topics: Arrhythmias, Cardiac; Dihydroxyphenylalanine; Humans; Hydrazines; Methyldopa; Parkinson Disease; Propionates	1971
Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor. Journal of neurology, neurosurgery, and psychiatry, 1971, Volume: 34, Issue:6 Topics: Adult; Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Dopa Decarboxylase; Humans; Hydrazines; Middle Aged; Parkinson Disease; Pyridazines; Pyridoxine	1971
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). Transactions of the American Neurological Association, 1971, Volume: 96 Topics: Dihydroxyphenylalanine; Drug Synergism; Humans; Hydrazines; Methyldopa; Parkinson Disease	1971
Coupling of hypotensive and anit-Parkinson effects with two dopaminergic drugs. Transactions of the Association of American Physicians, 1971, Volume: 84 Topics: Apomorphine; Blood Pressure; Brain; Carbidopa; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Synergism; Humans; Hydrazines; Hypotension; Parkinson Disease; Time Factors	1971
Levodopa in the treatment of Parkinsonism. JAMA, 1971, Dec-27, Volume: 218, Issue:13 Topics: Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dihydroxyphenylalanine; Dopamine; Esters; Humans; Hydrazines; Manganese Poisoning; Methylation; Methyldopa; Mice; Movement; Parkinson Disease; Parkinson Disease, Secondary; Phenylacetates	1971
Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism. Neurology, 1970, Volume: 20, Issue:12 Topics: 5-Hydroxytryptophan; Adult; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Hydrazines; Hydroxyindoleacetic Acid; Methyldopa; Middle Aged; Parkinson Disease; Phenylacetates	1970
[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)]. Neurologia, neurocirugia, psiquiatria, 1969, Volume: 10, Issue:1 Topics: Administration, Oral; Benzyl Compounds; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Humans; Hydrazines; Parkinson Disease	1969
Decarboxylase inhibitors for Parkinsonism. The New England journal of medicine, 1970, May-28, Volume: 282, Issue:22 Topics: Benzene Derivatives; Carboxy-Lyases; Humans; Hydrazines; Parkinson Disease	1970
Uptake of catecholamines into serotonergic nerve cells as demonstrated by fluorescence histochemistry. Experientia, 1971, Volume: 27, Issue:6 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Binding Sites; Catecholamines; Dihydroxyphenylalanine; Globus Pallidus; Histocytochemistry; Hydrazines; Hydroxyindoleacetic Acid; Medulla Oblongata; Microscopy, Fluorescence; Neurons; Parkinson Disease; Pons; Rats; Serotonin; Stereoisomerism	1971
[Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome]. La Presse medicale, 1969, Apr-05, Volume: 77, Issue:17 Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carboxy-Lyases; Chromatography; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Humans; Hydrazines; Monoamine Oxidase Inhibitors; Nervous System; Nervous System Physiological Phenomena; Parkinson Disease; Tranquilizing Agents	1969
New approaches in the treatment of parkinsonism. JAMA, 1969, Sep-01, Volume: 209, Issue:9 Topics: Acetylcholine; Amantadine; Blood-Brain Barrier; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrazines; Parkinson Disease	1969